Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
biochemistry, genetics and molecular biology
Synthesis, radiolabelling and biological evaluation of terminal oxamide derivatives of mercaptoacetyltriglycine
Journal of Labelled Compounds and Radiopharmaceuticals, Volume 45, No. 5, Year 2002
Notification
URL copied to clipboard!
Description
99mTc-MAG3 is widely used in clinical nuclear medicine as a potential replacement of 131I-OIH for renal function studies. The terminal carbonylglycine in the MAG3 backbone is assumed to be essential for maintaining its efficient renal handling characteristics. A number of MAG3-derivatives have been prepared and evaluated in which the terminal carbonylglycine sequence is substituted by an oxamide moiety in order to study the effect of the modified carbonylglycine sequence on the renal handling characteristics. These 'oxamide' derivatives have been synthesized starting from mercaptoacetic acid or cysteamine using the common synthetic procedures of peptide chemistry. These thiol-protected MAG3-precursors were labelled with 99mTC by an exchange method using tartrate as a complexing agent. Biodistribution studies in mice showed that some of these agents were cleared rapidly from the blood and efficiently excreted into the urine and displayed comparable renal excretion characteristics to those of 99mTc-MAG3. © 2002 John Wiley & Sons, Ltd.
Authors & Co-Authors
Okarvi, Subhani M.
Saudi Arabia, Riyadh
King Faisal Specialist Hospital and Research Centre
Torfs, P.
Saudi Arabia, Riyadh
King Faisal Specialist Hospital and Research Centre
Adriaens, Paul J.
Saudi Arabia, Riyadh
King Faisal Specialist Hospital and Research Centre
Verbruggen, Alfons Michel
Saudi Arabia, Riyadh
King Faisal Specialist Hospital and Research Centre
Statistics
Citations: 7
Authors: 4
Affiliations: 1
Identifiers
Doi:
10.1002/jlcr.568
ISSN:
03624803
Research Areas
Cancer
Health System And Policy